EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report
Breast metastasis from other primary carcinoma is very rare and could be difficult to identify despite immunohistochemistry analysis. Breast metastasis from lung adenocarcinoma can mimic triple-negative breast cancer. Given the prognosis and therapeutic challenges, a correct diagnosis appears essent...
Main Authors: | Eric Dansin, Aurélien Carnot, Véronique Servent, Dorothée Daussay, Yves-Marie Robin, Ecaterina Surmei-Pintilie, Géraldine Lauridant, Clothilde Descarpentries, Françoise Révillion, Claire Delattre |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2015-03-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/381014 |
Similar Items
-
Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
by: Aleksandra Simiczyjew, et al.
Published: (2018-09-01) -
Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer
by: Brooke N. McKnight, et al.
Published: (2020-04-01) -
Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor
by: Xie Y, et al.
Published: (2021-10-01) -
Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation
by: Olivia A. Sagan, et al.
Published: (2023-05-01) -
Worldwide variations in <it>EGFR </it>somatic mutations: a challenge for personalized medicine
by: Lamy Pierre-Jean, et al.
Published: (2012-02-01)